About the Clinical Electrophysiology laboratory
The Clinical Electrophysiology laboratory has a strong research plan with industry support of $250,000 with well supported interventional trials through national and international collaborations and population based studies which will likely have a significant impact on patient care in an important area of need (arrhythmias and heart failure) in an ageing population. The Electrophysiology unit is a large cardiology department supported by the Baker Heart and Diabetes Institute and with national and international collaborations with cardiology departments with extensive experience in clinical research, it provides the ideal opportunity for translation of research findings into clinical practice.
Through local, national and international collaboration, we are dedicated to reduce the burden of heart rhythm disorders including atrial fibrillation (AF) by:
- Identifying a safe level of alcohol intake in patients with AF and mild-moderate alcohol consumption.
- Catheter ablation in patients with unexplained heart failure and AF.
- Closing the gender gap in outcomes of catheter for atrial fibrillation between females and males.
- Population based studies to identify patients at risk of developing AF and those with AF more likely to progress to chronic AF to guide early intervention.
- Improving outcomes with catheter ablation in AF.
- Translation of scientific findings into clinical practice through advocacy and guidelines.